Chris Beyrer
Director, Duke Global Health Institute
Gary Hock Distinguished Professor in Global Health
Professor of Medicine
Research Professor of Global Health
Appointment:
Chris Beyrer
Director, Duke Global Health Institute
Gary Hock Distinguished Professor in Global Health
Professor of Medicine
Research Professor of Global Health
Chris Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, became director of the Duke Global Health Institute in August 2022.
Beyrer has led collaborative research on HIV epidemiology, prevention and treatment in Southeast Asia, Sub-Saharan Africa, and Eastern Europe and Central Asia for more than 30 years. He is past president of the International AIDS Society, the world’s largest body of HIV professionals, and currently serves as an advisor to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the HIV Vaccine Trials Network, the World Health Organization, and Physicians for Human Rights. The author of over 400 scientific papers, he was named in 2022 to the annual list of the world’s most cited scientists.
Before coming to Duke, Beyrer was the inaugural Desmond M. Tutu Professor of Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, where he served as associate director of the JHU Center for AIDS Research and the Center for Global Health. He was the founding director of the Center for Public Health and Human Rights. He received his medical degree from SUNY Downstate Health Sciences University and holds a Master of Public Health from Johns Hopkins Bloomberg School of Public Health. He was elected to the National Academy of Medicine in 2014 and serves on the Academy’s Board for Global Health and on the Committee for Human Rights.
Publications
-
Beyrer C. On going backwards. Lancet. 2025 Apr 26;405(10488):1457–8.Wallach S, Ratevosian J, Smith T, Duval K, Baral S, Beyrer C. Strategic Litigation, Public Health, and the Decriminalization of Same-Sex Sexual Intimacy: Lessons From Legal Challenges Across Former British Colonies. Am J Public Health. 2025 Apr 24;e1–10.Sullivan PS, Wall KM, Juhasz M, Millett G, Crowley J, Beyrer C, et al. Excess HIV infections and costs associated with reductions in HIV prevention services in the United States: Projection using real-world data. Cold Spring Harbor Laboratory. 2025.Cooney EE, Reisner SL, Poteat TC, Radix AE, Mayer KH, Beyrer C, et al. Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort. AJPM Focus. 2025 Apr;4(2):100313.
See more publications at Scholars@Duke